- Home
- TRIB vs TTNP Comparison
TRIB vs TTNP Comparison
Compare TRIB & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- TTNP
- Stock Information
- Founded
- TRIB 1992
- TTNP 1991
- Country
- TRIB Ireland
- TTNP United States
- Employees
- TRIB N/A
- TTNP N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRIB Health Care
- TTNP Health Care
- Exchange
- TRIB Nasdaq
- TTNP Nasdaq
- Market Cap
- TRIB 5.4M
- TTNP 5.4M
- IPO Year
- TRIB N/A
- TTNP 1996
- Fundamental
- Price
- TRIB $1.20
- TTNP $4.21
- Analyst Decision
- TRIB
- TTNP
- Analyst Count
- TRIB 0
- TTNP 0
- Target Price
- TRIB N/A
- TTNP N/A
- AVG Volume (30 Days)
- TRIB 2.4M
- TTNP 88.1K
- Earning Date
- TRIB 11-14-2025
- TTNP 08-14-2025
- Dividend Yield
- TRIB N/A
- TTNP N/A
- EPS Growth
- TRIB N/A
- TTNP N/A
- EPS
- TRIB N/A
- TTNP N/A
- Revenue
- TRIB $61,555,000.00
- TTNP N/A
- Revenue This Year
- TRIB $13.51
- TTNP N/A
- Revenue Next Year
- TRIB $13.14
- TTNP N/A
- P/E Ratio
- TRIB N/A
- TTNP N/A
- Revenue Growth
- TRIB 8.31
- TTNP N/A
- 52 Week Low
- TRIB $0.48
- TTNP $3.03
- 52 Week High
- TRIB $3.44
- TTNP $6.43
- Technical
- Relative Strength Index (RSI)
- TRIB 49.30
- TTNP 46.07
- Support Level
- TRIB $1.42
- TTNP $3.90
- Resistance Level
- TRIB $1.28
- TTNP $4.42
- Average True Range (ATR)
- TRIB 0.09
- TTNP 0.29
- MACD
- TRIB -0.03
- TTNP -0.00
- Stochastic Oscillator
- TRIB 26.67
- TTNP 59.43
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.